- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1373
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1373 companies
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$1.3b
Engages in the development of drugs for the treatment of advanced and refractory cancers.
7427
NT$30.70
7D
2.0%
1Y
-14.7%
MOA Life Plus
Market Cap: ₩60.6b
Engages in the medicine and consumer business in South Korea.
A142760
₩1,552.00
7D
-2.0%
1Y
-5.9%
Grace Therapeutics
Market Cap: US$42.9m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$3.08
7D
-1.3%
1Y
0.3%
Annovis Bio
Market Cap: US$42.7m
A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.
ANVS
US$2.13
7D
-9.4%
1Y
-74.2%
Covalon Technologies
Market Cap: CA$58.9m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.15
7D
-1.4%
1Y
-36.8%
Ascelia Pharma
Market Cap: SEK 400.3m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.47
7D
-11.3%
1Y
50.7%
Moberg Pharma
Market Cap: SEK 400.0m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.51
7D
-5.2%
1Y
-14.0%
Century Therapeutics
Market Cap: US$42.1m
A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.
IPSC
US$0.49
7D
-3.8%
1Y
-68.1%
Prince Pharmaceutical
Market Cap: NT$1.3b
Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
6935
NT$35.10
7D
25.1%
1Y
62.9%
Modalis Therapeutics
Market Cap: JP¥6.3b
Engages in the research and development of therapeutics to treat patients with serious genetic disorders.
4883
JP¥82.00
7D
1.2%
1Y
-11.8%
Techno Drugs
Market Cap: ৳5.1b
Manufactures and sells human and veterinary medicines in Bangladesh and internationally.
TECHNODRUG
৳38.60
7D
-5.2%
1Y
-14.2%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
0%
1Y
95.2%
Eone Diagnomics Genome Center
Market Cap: ₩57.4b
Provides genetic information analysis services in South Korea.
A245620
₩415.00
7D
0%
1Y
-76.1%
Malin
Market Cap: €35.5m
Through its subsidiaries, operates in the life sciences industry in Ireland and the United States.
MLC
€8.20
7D
4.5%
1Y
31.2%
Eutilex.Co.Ltd
Market Cap: ₩58.4b
Engages in the discovery and development of immunomodulatory antibody therapeutics to treat cancers and autoimmune diseases.
A263050
₩1,586.00
7D
-7.7%
1Y
-37.1%
Anxo Pharmaceutical
Market Cap: NT$1.2b
A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.
6677
NT$22.00
7D
-3.5%
1Y
-35.4%
Nippon Chemiphar
Market Cap: JP¥6.0b
Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.
4539
JP¥1,671.00
7D
3.2%
1Y
3.8%
Genetic Signatures
Market Cap: AU$61.3m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.27
7D
0%
1Y
-60.0%
Lunai Bioworks
Market Cap: US$39.9m
A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.
RENB
US$0.14
7D
-13.0%
1Y
-70.6%
Hayat Pharmaceutical Industries
Market Cap: د.أ28.2m
Engages in the manufacture and marketing of generic pharmaceutical products in Jordan.
HPIC
د.أ2.97
7D
-2.3%
1Y
17.9%
Xilio Therapeutics
Market Cap: US$39.3m
A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.
XLO
US$0.76
7D
-0.6%
1Y
1.0%
Haleos Labs
Market Cap: ₹3.5b
Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.
SMSLIFE
₹1,149.20
7D
-3.0%
1Y
-21.0%
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫1.0t
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫110,000.00
7D
0%
1Y
26.7%
Tdspharm
Market Cap: ₩54.8b
Researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally.
A464280
₩9,910.00
7D
-2.9%
1Y
-52.1%
Generation Bio
Market Cap: US$38.8m
A biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.
GBIO
US$5.72
7D
-4.3%
1Y
-75.3%
Novacyt
Market Cap: €33.2m
Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.
ALNOV
€0.45
7D
-1.3%
1Y
-39.4%
Trident Lifeline
Market Cap: ₹3.4b
Manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.
543616
₹296.00
7D
2.1%
1Y
-7.1%
Precision System Science
Market Cap: JP¥5.8b
Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.
7707
JP¥212.00
7D
-0.5%
1Y
-24.3%
Mabion
Market Cap: zł140.5m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł8.71
7D
-6.3%
1Y
-48.5%
Eagle Veterinary TechnologyLtd
Market Cap: ₩54.1b
Manufactures and sells animal health care products.
A044960
₩4,280.00
7D
-0.8%
1Y
-14.7%
Navamedic
Market Cap: NOK 383.3m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.50
7D
-1.8%
1Y
-29.5%
GW VitekLTD
Market Cap: ₩53.9b
Engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally.
A036180
₩577.00
7D
0%
1Y
-20.3%
Cytogen
Market Cap: ₩53.5b
A biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea.
A217330
₩2,320.00
7D
-5.7%
1Y
-67.2%
Jasper Therapeutics
Market Cap: US$37.9m
A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.
JSPR
US$2.33
7D
-10.0%
1Y
-87.6%
Rekah Pharmaceutical Industry
Market Cap: ₪126.1m
Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.
REKA
₪11.05
7D
-0.9%
1Y
-17.4%
Extrawell Pharmaceutical Holdings
Market Cap: HK$290.7m
An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.
858
HK$0.11
7D
-1.7%
1Y
245.5%